HE treatment of SCI is complex with many barriers to the patient's recovery, including limited ability of the adult CNS to regenerate, excessive scarring, and cavitation after injury. There is also the need for regenerating axons to form physiologically meaningful connections after injury. Investigators have attempted to overcome some of these barriers by using implantable scaffolds made of different materials, including biodegradable polymers 7,17 and other nondegradable materials such as polycarbonate and hydrogels. To date, no effective scaffold is available for use in the CNS, although implants for peripheral nerves are now commercially available (Neuragen; Integra Neurosciences, Plainsboro, NJ). Lessons from developing bone 16 and vascular grafts 8 have taught us that compatibility of mechanical properties (compressive and tensile) between the graft and host tissues is critical for successful implantation. These constraints seem to have been neglected in developing CNS scaffolds; most that have been reported on are either too hard or too soft. Another questionable trend in developing scaffolds for the CNS has been use of biodegradable materials, 7 which in our opinion may leave the regenerating axons with inadequate support; this would be separate from the problem of releasing potentially detrimental intermediary breakdown compounds. We have addressed both these problems by engineering a nonbiodegradable noninflammatory hydrogel material, PHEMA, to have mechanical properties compatible with in vivo spinal cord tissue. We tested mechanically engineered PHEMA in a rodent model of SCI and established that it elicits minimal inflammatory responses and scarring from host tissues, promotes angiogenesis, and is able to deliver growth factors that promote axonal regeneration. These preliminary Departments of Neurobiology and Anatomy, and Neurosurgery, Drexel University College of Medicine; and Drug Delivery Lab, Department of Chemical Engineering, Drexel University, Philadelphia, Pennsylvania Object. Spinal cord injury (SCI) is a complex pathological entity, the treatment of which requires a multipronged approach. One way to integrate different therapeutic strategies for SCI is to develop implantable scaffolds that can deliver therapies in a synergistic manner. Many investigators have developed implantable "bridges," but an important property of such scaffolds-that is, mechanical compatibility with host tissues-has been neglected. In this study, the authors evaluated the results of implanting a mechanically matched hydrogel-based scaffold to treat SCI.
results set the stage for further enhancing the properties of mechanically engineered PHEMA to make it an effective multifunctional scaffold for the treatment of SCI.
Materials and Methods

Scaffold Synthesis
Sponge synthesis followed the reaction scheme previously reported. 3 Briefly, 2-hydroxyethylmethacrylate (Aldrich Chemical Co., Milwaukee, WI) was polymerized in a free radical solution polymerization. To remove the inhibitor, 4-methoxyphenol, hydroxyethylmethacrylate was first passed through an exchange column (DEHIBT 200; Polysciences, Inc., Warrington, PA). All other chemicals were used as received. Tetraethylene glycol dimethacrylate (Polysciences, Inc.,Warrington, PA) was used as the cross-linking agent with a cross-linking density of 1 mol%. The initiator, 2,2 azo-bisisobutryonitrile (Aldrich Chemical Co.), was added in the amount 1 wt % total monomers. The PEG grafts were incorporated into some of the sponges by the addition of PEG 200 monomethylethermonomethacrylate (Polysciences, Inc.) to the reaction mixture. Polyethylene glycol methacrylate was added at 6.5 mol% of the total monomer content. To address solubility issues, all reactants and the initiator were mixed prior to the inclusion of water. The monomer mixtures were then diluted to between 10 and 40 vol% with deionized water (18 M⍀; Barnstead E-Pure, Dubuque, IA). Argon was bubbled through the reaction mixture for 10 minutes to remove any dissolved O 2 . Synthesis proceeded in a water bath set at 70˚C for 1 hour. The resulting hydrogel sponges were then placed into deionized water for several days to remove any unreacted monomer and sol fraction present.
Scanning Electron Microscopy
Scanning electron microscopy micrographs were obtained of both the internal and external structure of all sponges that were analyzed. Freeze-dried samples, both freeze-fractured and nonfreezefractured, were gold sputter coated (Denton Desk 1 Cold Sputter/ etch, 35mA; Denton Vacuum, Inc., Cherry Hill, NJ) to obtain a conductive coating visible by the scanning electron microscopy. All micrographs were obtained using a scanning electron microscope (model 1830; Amray, Inc., Bedford, MA). For all samples, the accelerating potential was set at 20 kHz to obtain greater contrast of the porous surface, and the working distance was set at 25 mm.
Mechanical Analysis
An automated materials tester (model 4422; Instron, Canton, MA) was used to obtain bulk compressive moduli. Cylindrical samples were cut to maintain a height/diameter ratio of 3:1. The top and bottom edges of the samples were evaluated to ensure that only right cylinder geometries were used. Prior to evaluation, all samples were equilibrated in solutions of phosphate-buffered saline, pH 7.4, at 37˚C. Each sample was kept in the 37˚C water bath until the compression test was performed. The strain rate was set at 50% compression/minute, and force compared with cross-head movement was recorded. The bulk polymer compressive response was also determined to compare the effect of relative porosity on the compressive strength of samples. Because the hydrogel samples that we used possess high deformations, it was assumed that the cross-head travel distance was equal to the amount of deformation of the sample. The compressive modulus was found from the stress-strain curves where the force was normalized using the force per swollen uncompressed cross-sectional area.
Surgical Implantation
A partial cervical hemisection model in the rat was chosen to test the characteristics of PHEMA after implantation. This model has been developed by our group 12 and has the advantage of causing a small focal injury to the lateral columns of the spinal cord (completely ablating the lateral funiculus) without causing major morbidity or death in the animals. All surgeries were performed according to the guidelines of the Drexel University Institutional Animal Care and Use Committee. Two groups of 12 rats underwent surgical lesioning followed by implantation of PHEMA that had been reconstituted with saline or the PHEMA soaked in 1 g BDNF (gift of Regeneron, Inc., Tarrytown, NY). Four animals from each group were killed after 7, 14, and 28 days, respectively. All animals were perfused with 4% paraformaldehyde followed by cryoprotection in 30% sucrose. Sections were frozen in TissueTek and 20-m-thick sagittal sections were cut in the cryostat.
Histological Examination
Nissl staining was performed using standard protocols, and images were obtained on a microscope (model DMRBE; Leica, Inc., Wetzlar, Germany). For immunohistological testing, the following antibodies were used: Sigma-Aldrich, 1:200). Selected sections were hydrated with phosphate-buffered saline followed by blocking with 10% goat serum for 1 hour. Primary antibodies were prepared at stated dilutions in 2% goat serum with Triton and incubated overnight at room temperature. After rinsing the primary antibodies, secondary antibodies were applied for 2 hours at room temperature in darkness. The following secondary antibodies were used: rhodamine-goat antirabbit, FITC-donkey antimouse, and FITC-goat antimouse. All secondary antibodies (Jackson Immunoresearch, West Grove, PA) were used at 1:200 dilutions. After rinsing the secondary antibodies, slides were placed on cover slips with VectaShield Hardset containing DAPI for nuclear staining.
Histological Quantitation. An estimation of the extent of inflammatory response to implanted PHEMA was made by determining the size of the perilesional cuff of inflammatory cells on Nissl-stained sections. The size of the cuff was measured in a direction perpendicular to the cord-implant interface by using the "measure" function in Adobe Photoshop software, and appropriate scale correction was made. All of the measurements were made and the mean cuff size was obtained for each group. The subsequent procedure was followed for quantitation of gliosis and proteoglycan expression. Two boxes of equal size were defined in each immunohistochemically stained section and placed at the implant-host interface. Image J software (provided by the National Institutes of Health) was then used to estimate the area fraction of each stain (red for GFAP and green for CSPG). Area fractions from both boxes were averaged, and mean area fractions for each group were calculated. Statistical analysis was performed using the Student t-test and significance levels were determined.
Confocal Microscopy
All immunofluorescence images were acquired on the confocal laser scanning TCS SP2 microscope (Leica, Inc.). One-micrometerthick optical sections were obtained across the z axis of the tissue and a z stack was created. The maximal projection of this stack was then used for image analysis. Appropriate filters were used for rhodamine, FITC, and DAPI spectra. Some images were obtained using differential interference contrast microscopy and fused with the fluorescence microscopy images by using the Leica overlap function.
Results
Mechanical Properties
The mechanical properties of PHEMA can be manipulated by modifying the solvent volume fraction in the reaction mixture. As Fig. 1 left shows, the compressive modulus of PHEMA falls with increasing water content. It approaches 3 to 5 kPa, which is the modulus range of normal spinal cord, 20 when the water content of PHEMA is maintained at 85%. Based on these results and the hypothesis that mechanical compatibility is essential for successful graft incorporation into the host tissues, all further experiments were performed using 85% PHEMA. Scanning electron microscopy ( Fig. 1 right) demonstrated that 85% PHEMA had multiple interconnected pores that ranged in size from 10 to 20 m.
Surgical Handling
We observed that PHEMA was very easy to handle and implant into the surgical cavity created in the spinal cord (Fig. 2) . Because of its well-matched mechanical properties, PHEMA filled the lesion cavity and conformed to its contours without producing undue pressure on the spinal cord.
Inflammatory Response
Analysis of the Nissl-stained tissue revealed presence of a cuff of mononuclear and polymorphonuclear infiltrate around the implanted PHEMA 7 days after surgery, indicating a moderate inflammatory response (Fig. 3a) . This response declined with the passage of time and by the end of 4 weeks, almost no inflammatory cells were seen either around the grafted PHEMA or within its substance ( Fig.  3b and c) . Semiquantitative analysis of the perilesional inflammatory cuff confirmed the decline in the extent of inflammation with time, as shown in Fig. 3d .
Immunohistological analysis of macrophage infiltration was performed using ED-1 antibody to label activated macrophages. This analysis revealed that there was considerable macrophage infiltration around the implanted PHEMA 1 week after surgery, but the number of macrophages was reduced with the passage of time, and by 4 weeks only a few isolated macrophages remained ( Fig. 3e  and f) . This correlates well with the Nissl staining analyses that confirmed a reduction in the extent of inflammation around the implanted hydrogel.
Scarring Postinjury
Scarring after injury has been one of the major impediments to regenerating axons. We tested the scarring pattern after PHEMA implantation by using CSPG and GFAP as markers of ECM scarring and gliosis, respectively. Immunohistological analysis with CSPG markers revealed a reduction in the level of CSPG staining 4 weeks after implantation of PHEMA in comparison with a high level of staining after 1 week (Fig. 4) . We noted absence of any significant gliosis around the implanted PHEMA even 4 weeks after surgery (Fig. 4) . Semiquantitative analysis was performed to estimate the extent of GFAP and CSPG expression over time and these results are shown in Fig. 4c . The extent of GFAP and CSPG staining is expressed as the area fraction occupied by the stained cells in the perilesional area, and Fig. 4c reveals that there is a significant reduction in CSPG expression over time. Furthermore, gliosis does not increase with the passage of time. These data indicate that PHEMA is well accepted by host CNS tissues and that PHEMA does not elicit significant scarring. Interestingly, we did not note any astrocytic invasion of the implanted PHEMA.
Confirmation of Angiogenesis
Growth of new blood vessels into an implanted matrix has been considered to be one of the basic requirements of successful tissue engineering. We demonstrated angiogenesis by performing immunohistological studies in which laminin was used as a marker of the basement membrane and RECA-1 as a marker of vascular endothelial cells. Confocal microscopy was performed to confirm colocalization of both markers used to identify viable newly formed vascular structures within the implanted scaffolds.We noted that angiogenesis began early after implantation of PHEMA, with many new blood vessels penetrating the graft-host interface (Fig. 5a) . Within 2 weeks, new vessels were seen to occupy the entire PHEMA scaffold (Fig. 5b) , and these blood vessels persisted until 4 weeks after implantation (Fig. 5c) . The spatial distribution of new blood vessels within the implanted PHEMA indicates a gradual penetration of the implant with more peripheral distribution of vessels during the early time points (Fig. 5a  and b) ; however, by 4 weeks the entire implanted gel seems to be occupied by viable new blood vessels (Fig. 5c) .
Axonal Regeneration
Finally, we tested to see whether PHEMA delivered growth factors that might allow host axons to penetrate its substance. Although unmodified PHEMA does not support significant axonogenesis (Fig. 6a) , PHEMA soaked with BDNF induced considerable axonal growth within the implanted hydrogel by 1 week (Fig. 6b) . These new axons persist for 2 weeks after implantation (Fig. 6c ) but their numbers diminish by 4 weeks after surgery. The growth of new axons demonstrates that not only can PHEMA deliver growth factors, but also that the porosity and mechanical properties of PHEMA are adequate to provide support to regenerating axons, provided that the local neurochemical environment is appropriate for axonal regeneration. Interestingly, BDNF-soaked PHEMA did not show any significant differences from unmodified PHEMA with respect to inflammatory cells, gliosis, and angiogenic invasion. tissues into the human body, including peripheral nerves (autologous sural nerves), bone (autologous bone, bank bone, or metal implants), and blood vessels (autologous vessels or Gortex implants). From these surgical experiences, neurosurgeons have realized that one of the most important parameters of successful graft uptake by the host tissues is mechanical compatibility. A mechanically mismatched bone or vascular graft is doomed to fail. 8, 16 Similar to bone or blood vessels, the CNS is a very dynamic tissue that moves and pulsates along with cardiac and respiratory rhythms, 13 which mandates a mechanical constraint on scaffolds developed for grafting into the CNS, something that has been neglected in the past. We have developed an implantable scaffold that matches the mechanical properties of spinal cord tissue, and we have tested its performance in an in vivo SCI model.
Discussion
Mechanical Properties
Hydrogel scaffolds have previously been used as transplant materials in SCI by us and others. 3, 4, 11, 17, 21, 25 We have used alginate-based hydrogels to encapsulate genetically modified fibroblasts that secrete BDNF, which have demonstrated effective drug delivery. 23 Woerly, et al., 25 performed studies to establish the biocompatibility of PHPMA and enhanced the basic scaffold by conjugating it with ECM peptide motifs (RGD/Arg-Gly-Asp). These investigators have attempted to match the mechanical properties of PHPMA with that of brain tissue; however, in a more recent paper 11 they observed that PHPMA hydrogels were associated with a massive ingrowth of connective tissue elements, in contrast to PHEMA that allowed only astrocytic ingrowth. Their studies do not give detailed histological characteristics of PHEMA, a lacunae addressed in this paper. Other investigators have conducted experiments 5, 21 to design a hydrogel implant that approximates the mechanical properties of the nervous tissue. These studies, however, involved the use of baseline spinal cord properties obtained in studies conducted more than 15 years ago; the techniques used for measuring the moduli of spinal cord were quite dated. 2, 24 In a recent report by Ozawa, et al., 19 they used the more accurate pipette aspiration method with which the parenchymal modulus is measured directly; we have used these values to design our scaffold. These later studies reveal the correct elastic modulus of the spinal cord parenchyma to be in the range of 3 to 4 kPA, two orders of magnitude different from those used by earlier investigators. The intuitive feel of the matched mechanical properties is felt by the neurosurgeon at the time of implantation into the spinal cord, as demonstrated in Fig. 2 . PHEMA sponges, which had long been neglected as biomaterial. The established that sponges produced with more than 75% water in the monomer mixture displayed contiguous pores between 10 and 30 m in size, were biocolonized through cellular invasion, and produced ECM. 24 Based on these studies, Chirila has developed a PHEMAbased artificial cornea (keratoprosthesis), which is now Food and Drug Administration approved and undergoing advanced clinical trials (AlphaCor). 10 Early results with PHEMA keratoprosthesis have been very encouraging. We have chosen to use PHEMA as the starting material for a multifunctional scaffold in the CNS. In addition to exquisite control over mechanical properties, PHEMA also allows control over the cellular responses generated by the host tissue. We have noted excellent performance characteristics of PHEMA after implantation in an SCI model. The inflammatory cuff diminishes in size and intensity over a period of 4 weeks, and this histological picture is corroborated by immunohistological analysis of ED-1-positive macrophages. In addition, the scarring produced by PHEMA is minimal, with no visible gliosis even 4 weeks after implantation. Reduction of CSPG expression is a major advantage with PHEMA, something that has not been noted with any other scaffold implanted in the CNS. This reduction in CSPG expression might turn out to be one of the most important features of PHEMA as a CNS implant, as CSPG and other ECM proteoglycans are well recognized as major impediments to axonal regeneration. Any material that diminishes CSPG production will have significant advantages over other materials that do not possess this property. In our work with PHEMA sponges, we have incorporated small amounts of low-molecular PEG grafts. The presence of these moieties has been shown to result in the formation of sponges with a more homogeneous pore size distribution and greater pore interconnection. The presence of PEG has also caused these matrices to be increasingly permissive to endothelial cell penetration and tubule formation, which is the precursor to angiogenesis. 6, 7 Angiogenesis. Angiogenesis in the implanted scaffold has been considered to be one of the most important performance characteristics of biomaterials. Porosity of the implant material plays an important role in determining its acceptability by the host tissue. Brauker, et al., 1 evaluated the foreign body responses elicited by more than 150 membranes of various pore sizes. Among the membranes tested pore size and not chemical composition appeared to be the primary determinant of the foreign body response.
Membranes of pore sizes of 5 to 15 m, or vascularizing membranes consistently resulted in vascularized capsules. Appropriate angiogenesis in the implanted scaffold can prevent the exclusion of the graft via formation of a fibrous capsule around the biomaterial 6 and help hold the implant in place. 4 Apart from these mechanistic considerations, angiogenesis plays a very important biological role by providing nutritional and O 2 support to growing tissues, which have high requirements for such support, as well as for transplanted stem cells. Stem cell transplantation is proving to be one of the most promising biological advances that might yield novel therapeutic strategies; however, poor survival of transplanted stem cells has impeded the progress of this field. Appropriately vascularized scaffolds are more likely to support transplanted cells.
We have used a unique double-labeling technique that identifies laminin as the basement membrane and RECA as a marker for endothelium, and coexpression of these two markers has been used as evidence of presence of viable blood vessels capable of supporting blood flow.
14 Efforts have been made to improve angiogenesis in implanted scaffolds by releasing growth factors. 20 Our results in the present study demonstrate that PHEMA supports excellent angiogenesis that starts as early as 1 week postadministration, and large numbers of viable blood vessels with an endothelial lining are noted within the substance of the hydrogel as late as 4 weeks after surgery.
Axonogenesis. The holy grail of biomaterial implants into the CNS is achieving axonal regeneration across the implant material. Other groups have demonstrated some axonal penetration with different materials, but limitations with material structure have either led to a collapse of the scaffold 18 or excessive scarring and gliosis. 7 In this study, we have demonstrated the possibility of promoting axonal growth by delivering BDNF adsorbed to PHEMA. Our group previously demonstrated that soaking Gelfoam with different growth factors provides a very transient period of physiological levels of the growth factors, 3 which is sufficient to exert a brief effect. 22 Similar conclusions can be made about PHEMA in the present experiment; however, unlike Gelfoam, PHEMA is amenable to further modifications that will lead to a much more sustained release of the growth factors. In addition, earlier investigators have referred to the desirability of having surface selectivity of implanted scaffolds that permits attachment of axons and growth cones (and possibly astrocytes) and yet wards off other cells that are actively inhibitory. 7 Based on the results of experiments reported here we submit that PHEMA has all of these features. We have shown that mechanically engineered PHEMA elicits a minimal inflammatory response, supports angiogenesis that is vital for regenerating tissues, excludes macrophages, and still permits the selective penetration of axons once adequate levels of growth factors are provided.
Finally, based on the results presented here, we argue that the emphasis placed on biodegradable implants in the literature heretofore is misplaced. Not enough attention has been given to the fact that axons are very delicate structures and require a fair amount of support such as that provided by glia in the normal circumstances. In the absence of such an elaborate network within an injury site, it stands to reason that such support should be provided by the scaffold structure itself. Biodegradable implants deny axons that support by disappearing just when the axons might need them the most. The biomaterial presented here is 85% water and after implantation is well accepted by the host tissue, with excellent angiogenesis and for the time being marginal axonogenesis. We are in the process of developing strategies to achieve sustained release of multiple therapeutic peptides from the implanted PHEMA. Having established the excellent baseline performance characteristics of mechanically engineered PHEMA in the present study, we now propose to enhance the properties of this platform technology by making it supportive of transplanted stem cells and by delivering multiple physiologically synergistic therapeutic peptides. We also propose further studies to characterize long-term (6 months-1 year) performance of the enhanced PHEMA in SCI models.
Conclusions
We have demonstrated that PHEMA with an 85% water content had a compressive modulus of 3 to 4 kPa, which matched that of the spinal cord. Implanted PHEMA elicited modest cellular inflammatory responses that disappeared by 4 weeks postimplantation. Minimal scarring was noted around the matrix. Considerable angiogenesis was observed in PHEMA, and PHEMA soaked in BDNF promoted axonal penetration into the gel. We conclude that mechanically engineered PHEMA is well accepted by host tissues and might be used as a platform for sustained drug delivery to promote axonal regeneration and functional recovery after SCI.
